Designing Visual Tools to Enhance Cancer Surgeon Decision-making

Part of paid clinical trials in Chapel Hill, North Carolina.

Sponsor
UNC Lineberger Comprehensive Cancer Center
Study ID
NCT06965192
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Visual — BEHAVIORAL
    Physician participants will view the visual decision support before entering the patient's room during the intervention period, with the option to share with the patient.
  • No intervention — OTHER
    No intervention

Study Details

This prospective study will compare pre-post pilot test of surgeon-facing, visual decision support among urologists seeing patients with newly diagnosed localized prostate and kidney cancer. Up to 20 urologists (10 academic and 10 community) will be enrolled. The goal will be to capture up to 10 pre- and 10 post-intervention patient encounters for each urologist with an accrual target of 200 unique patient visits (100 pre and 100 post-intervention) over a half-year period. Patient encounters pre- and post-intervention will be audio recorded, transcribed, and coded for discussion of risks/benefits of surgery and strength of recommendation. Patients and urologists will complete additional surveys on their perceptions of patient-provider communication. Urologists will further describe their experience and rate their satisfaction with visual decision support. Communication (content and perceived) will be compared pre- and post-intervention with secondary comparisons by race and care setting. It was hypothesized that the discussion of risks and benefits of cancer surgery will increase post-intervention and that the strength of recommendation and perceptions of patient-provider communication will change. The secondary hypothesis is that these changes will differ by patient race and care setting.

Key Dates

Start date
Apr 24, 2025
Status verified
Dec 2025
Primary completion
Jun 30, 2027
Completion
Jan 30, 2028

Study Design

Enrollment
220 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Patient participants
    Patient participants will complete a 10-minute baseline survey, 15-minute after-visit survey and 5-minute 6-month survey.
  • Experimental: Physician participants
    Physician participants seeing patients with newly diagnosed localized prostate cancer and clinical T1 renal masses suspicious for kidney cancer.

Primary Outcome Measure

Discussion of Risks and Benefits [ Time Frame: Baseline (Patient-Physician Encounter) ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
UNC Lineberger Comprehensive Cancer CenterChapel HillNorth Carolina27599
Deborah M Usinger
[email protected]
919-962-0000
Taylor L Greene
[email protected]
(919) 962-0000
Hung-Jui Tan, MD, MSHPM (PRINCIPAL_INVESTIGATOR)
New Hanover Regional Medical CenterWilmingtonNorth Carolina28401
Natara Dulaney
[email protected]

Find similar trials in Chapel Hill, NC

By condition
Kidney cancerProstate cancer
By specialty
OncologyUrologyProstate oncologyMen's health
By research site
UNC Lineberger Comprehensive Cancer Center· Chapel Hill, NCNew Hanover Regional Medical Center· Wilmington, NC

Related Studies